Galenica Sustainability and Business Performance
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Swiss pharmaceutical market:
Development by channel 2022 (YTD June)
Value (ex-factory): CHF 3,432.6
CHF +227.1 million / +7.1%
Volume (packs): 97.5 million
+10.5 million / +12.1%
0.9%
25.3%
Pharmacies
8.5%
CHF 1,642.4 million, +8.5%
3.4%
Pharmacies: stationary
1,472.0 Mio., +8.5%
42.9%
Pharmacies: mail-order
22.4%
170.3 Mio., +8.2%
■Physicians
CHF 889.1 million, +6.0%
25.9%
Drugstores
1.0%
5.0%
CHF 32.1 million, +12.6%
Hospitals
CHF 869.1 million, +5.4%
Source: APO/SD/DRO/SPI Index, Swissmedic A, B, D
Medicines Swissmedic lists A, B, D, sold from suppliers and wholesalers to hospitals, physicians and drugstores
© IQVIA Switzerland - Swiss pharmaceutical market 2022 YTD June
08/08/22
30
64.7%
Pharmacies
64.1 million, +14.4%
■ Pharmacies: stationary
63.1 Mio., +14.7%
Pharmacies: mail-order
1.0 Mio., -1.7%
■Physicians
21.9 million, +7.2%
■Drugstores
3.3 million, +17.2%
■Hospitals
8.3 million, +7.0%
GALENICAView entire presentation